Miranda-Pettersen K, Morais-de-Jesus M, Daltro-Oliveira R, Duarte DAD, Teles C, Schinoni MI, Miranda-Scippa Á, Paraná R, Quarantini LC

Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 310-316
Archivo PDF: 98.33 Kb.

RESUMEN

Sin resumen

REFERENCIAS (EN ESTE ARTÍCULO)

1. Pavan K, Schmidt K, Marangoni B, Mendes MF, Tilbery CP, Lianza S. Esclerose Multipla: Adaptação transcultural e validação da escala modificada de impacto da fadiga. Arq Neuropsiquiatr 2007; 65: 669-73.

2. Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J. Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol 2000; 95: 760-7.

3. Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004; 56: 157-70.

4. Arnold LM. Understanding fatigue in major depressive disorder and other medical disorders. Psychosomatics 2008; 49: 185-90.

5. Fisk JD, Doble SE. Construction and validation of a fatigue impact scale for daily administration (D-FIS). Qual Life Res 2002; 11: 263-72.

6. Hassoun Z, Willems B, Deslauriers J, Nguyen BN, Huet PM. Assessment of fatigue in patients with chronic hepatitis C using the Fatigue Impact Scale. Dig Dis Sci 2002; 47: 2674-81.

7. Hilsabeck RC, Hassanein TI, Perry W. Biopsychosocial predictors of fatigue in chronic hepatitis C. J Psychosom Res 2005; 58: 173-8.

8. Marcellin F, Preau M, Ravaux I, Dellamonica P, Spire B, Carrieri MP. Self-reported fatigue and depressive symptoms as main indicators of the quality of life (QOL) of patients living with HIV and Hepatitis C: implications for clinical management and future research. HIV Clin Trials 2007; 8: 320-7.

9. Prince MI, James OFW, Holland NP, Jones DEJ. Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol 2000; 32: 368-73.

10. Seaman K, Paterson BL, Vallis M, Hirsch G, Peltekian KM. Future directions for investigation of fatigue in chronic hepatitis C viral infection. Chronic Illness 2009; 5: 115-28.

11. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clinical Infectious Diseases 1994; 18: S79.

12. Frith J, Newton J. Fatigue impact scale. Occupational Medicine 2010; 60: 159.

13. Martinez-Martin P, Catalan MJ, Benito-Leon J, Moreno AO, Zamarbide I, Cubo E, van Blercon N, et al. Impact of fatigue in Parkinson’s disease: the Fatigue Impact Scale for Daily Use (D-FIS). Qual Life Res 2006; 15: 597-606.

14. Benito-Leon J, Martinez-Martin P, Frades B, Martinez-Gines ML, de Andres C, Meca-Lallana JE, Antiguedad AR, et al. Impact of fatigue in multiple sclerosis: the Fatigue Impact Scale for Daily Use (D-FIS). Mult Scler 2007; 13: 645-51.

15. Amorim P. Mini International Neuropsychiatric Interview (MINI): validação de entrevista breve para diagnóstico de transtornos mentais. Rev Bras Psiquiatr 2000; 22: 106-15.

16. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol 1999; 39: 143-50.

17. Lohr KN. Assessing health status and quality-of-life instruments: attributes and review criteria. Quality of Life Research 2002; 11: 193-205.

18. Husted JA, Cook RJ, Farewell VT, Gladman DD. Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol 2000; 53: 459-68.

19. Garcia de Yebenes Prous MJ, Salvanes FR, Ortells LC. Responsiveness of outcome measures. Reumatologia Clinica [English edition] 2008; 4: 240-7.

20. Martins T, Narciso-Schiavon JLUZ, Schiavon LDEL. Epidemiologia da infeccao pelo virus da hepatite C. CEP:88704:900.

21. Karaivazoglou K, Iconomou G, Triantos C, Hyphantis T, Thomopoulos K, Lagadinou M, Gogos C, et al. Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL). Ann Hepatol 2010; 9: 419-27.

22. Bland JM, Altman DG. Statistics notes: Cronbach’s alpha. BMJ 1997; 314: 572.